1. Dominguez LJ, Veronese N, Barbagallo M. Dietary Patterns and Healthy or Unhealthy Aging. Gerontology. 2024;70(1):15-36. [DOI:10.1159/000534679]

2. Moulavi P, Ahmadi A, Masoumi SJ, Zare M, Honardoust M, Ranjbar R. Relationship between TyG-BMI index and glycemic index with diet quality, anthropometric indices, and blood pressure in patients with metabolic syndrome. Medicine (Baltimore). 2025;104(3):e41276. [DOI:10.1097/MD.0000000000041276]

3. Wang X, Xu M, Li Y. Adipose Tissue Aging and Metabolic Disorder, and the Impact of Nutritional Interventions. Nutrients. 2022;14(15). [DOI:10.3390/nu14153134]

4. Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, et al. The Role of Adipokines in Health and Disease. Biomedicines. 2023;11(5). [DOI:10.3390/biomedicines11051290]

5. Ottum MS, Mistry AM. Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance. J Clin Biochem Nutr. 2015;57(1):1-12. [DOI:10.3164/jcbn.15-3]

6. Maasen K, van Greevenbroek MMJ, Scheijen J, van der Kallen CJH, Stehouwer CDA, Schalkwijk CG. High dietary glycemic load is associated with higher concentrations of urinary advanced glycation endproducts: the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) Study. Am J Clin Nutr. 2019;110(2):358-66. [DOI:10.1093/ajcn/nqz119]

7. Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7(1):402. [DOI:10.1038/s41392-022-01257-8]

8. Serrano-Marco L, Chacón MR, Maymó-Masip E, Barroso E, Salvadó L, Wabitsch M, et al. TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes. Biochim Biophys Acta. 2012;1821(9):1177-85. [DOI:10.1016/j.bbalip.2012.05.006]

9. Baechle JJ, Chen N, Makhijani P, Winer S, Furman D, Winer DA. Chronic inflammation and the hallmarks of aging. Mol Metab. 2023;74:101755. [DOI:10.1016/j.molmet.2023.101755]

10. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375-c91. [DOI:10.1152/ajpcell.00379.2020]

11. Anderson C, Milne GL, Park YM, Sandler DP, Nichols HB. Dietary Glycemic Index and Glycemic Load Are Positively Associated with Oxidative Stress among Premenopausal Women. J Nutr. 2018;148(1):125-30. [DOI:10.1093/jn/nxx022]

12. Arikawa AY, Jakits HE, Flood A, Thomas W, Gross M, Schmitz KH, et al. Consumption of a high glycemic load but not a high glycemic index diet is marginally associated with oxidative stress in young women. Nutr Res. 2015;35(1):7-13. [DOI:10.1016/j.nutres.2014.10.005]

13. Gregersen S, Samocha-Bonet D, Heilbronn LK, Campbell LV. Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans. J Nutr Metab. 2012;2012:238056. [DOI:10.1155/2012/238056]

14. Chiu DT, Hamlat EJ, Zhang J, Epel ES, Laraia BA. Essential Nutrients, Added Sugar Intake, and Epigenetic Age in Midlife Black and White Women: NIMHD Social Epigenomics Program. JAMA Netw Open. 2024;7(7):e2422749. [DOI:10.1001/jamanetworkopen.2024.22749]

15. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants. Jama. 2025;333(1):71-4. [DOI:10.1001/jama.2024.21972]

16. Willett W. Nutritional epidemiology: Oxford university press; 2012. [DOI:10.1093/acprof:oso/9780199754038.001.0001]

17. Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654-62. [DOI:10.1017/S1368980009991698]

18. Taleban F, Esmaeili M. Glycemic index of Iranian foods: Guideline for diabetic and hyperlipidemic patients. Tehran: National Nutrition and Food Technology of Iran, Shahid Beheshti University of Medical Science. 1999;1:1-16.

19. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values: 2002. Am J Clin Nutr. 2002;76(1):5-56. [DOI:10.1093/ajcn/76.1.5]

20. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253.

21. Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073-80.

22. Behtaj D, Ghorbani A, Eslamian G, Malekpour Alamdari N, Abbasi M, Zand H, et al. Ex vivo Anti-Senescence Activity of N-Acetylcysteine in Visceral Adipose Tissue of Obese Volunteers. Obes Facts. 2024;17(4):355-63. [DOI:10.1159/000539255]

23. Masoodian SM, Omidifar A, Moradkhani S, Asiabanha M, Khoshmirsafa M. HOMA-IR mean values in healthy individuals: a population-based study in iranian subjects. J Diabetes Metab Disord. 2023;22(1):219-24. [DOI:10.1007/s40200-022-01099-9]

24. Fahim NK, Negida A, Fahim AK. Sample size calculation guide-part 3: how to calculate the sample size for an independent case-control study. Advanced Journal of Emergency Medicine. 2019;3(2):e20-e.

25. Teymoori F, Farhadnejad H, Mirmiran P, Nazarzadeh M, Azizi F. The association between dietary glycemic and insulin indices with incidence of cardiovascular disease: Tehran lipid and glucose study. BMC public health. 2020;20(1):1496. [DOI:10.1186/s12889-020-09586-5]

26. Lee MJ, Kim J. The pathophysiology of visceral adipose tissues in cardiometabolic diseases. Biochemical pharmacology. 2024;222:116116. [DOI:10.1016/j.bcp.2024.116116]

27. Fuster JJ, Ouchi N, Gokce N, Walsh K. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circulation research. 2016;118(11):1786-807. [DOI:10.1161/CIRCRESAHA.115.306885]

28. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nature medicine. 2009;15(9):1082-7. [DOI:10.1038/nm.2014]

29. Espinosa De Ycaza AE, Søndergaard E, Morgan‐Bathke M, Carranza Leon BG, Lytle KA, Ramos P, et al. Senescent cells in human adipose tissue: a cross‐sectional study. Obesity. 2021;29(8):1320-7. [DOI:10.1002/oby.23202]

30. Sohouli MH, Eslamian G, Malekpour Alamdari N, Abbasi M, Fazeli Taherian S, Behtaj D, et al. Effects of N-acetylcysteine on aging cell and obesity complications in obese adults: a randomized, double-blind clinical trial. Frontiers in nutrition. 2023;10:1237869. [DOI:10.3389/fnut.2023.1237869]

31. Villaret A, Galitzky J, Decaunes P, Estève D, Marques MA, Sengenès C, et al. Adipose tissue endothelial cells from obese human subjects: differences among depots in angiogenic, metabolic, and inflammatory gene expression and cellular senescence. Diabetes. 2010;59(11):2755-63. [DOI:10.2337/db10-0398]

32. Tchkonia T, Giorgadze N, Pirtskhalava T, Thomou T, Villaret A, Bouloumie A, et al., editors. Cellular senescence and inflammation in obesity. Obesity; 2009: NATURE PUBLISHING GROUP 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA.

33. Vlachos D, Malisova S, Lindberg FA, Karaniki G. Glycemic Index (GI) or Glycemic Load (GL) and Dietary Interventions for Optimizing Postprandial Hyperglycemia in Patients with T2 Diabetes: A Review. Nutrients. 2020;12(6). [DOI:10.3390/nu12061561]

34. Coate KC, Huggins KW. Consumption of a high glycemic index diet increases abdominal adiposity but does not influence adipose tissue pro-oxidant and antioxidant gene expression in C57BL/6 mice. Nutr Res. 2010;30(2):141-50. [DOI:10.1016/j.nutres.2010.01.003]

35. Clemente-Suárez VJ, Redondo-Flórez L, Beltrán-Velasco AI, Martín-Rodríguez A, Martínez-Guardado I, Navarro-Jiménez E, et al. The role of adipokines in health and disease. Biomedicines. 2023;11(5):1290. [DOI:10.3390/biomedicines11051290]

36. Pawlak DB, Bryson JM, Denyer GS, Brand-Miller JC. High glycemic index starch promotes hypersecretion of insulin and higher body fat in rats without affecting insulin sensitivity. J Nutr. 2001;131(1):99-104. [DOI:10.1093/jn/131.1.99]

37. Elmitwalli O, Darwish R, Al-Jabery L, Algahiny A, Roy S, Butler AE, et al. The emerging role of p21 in diabetes and related metabolic disorders. International Journal of Molecular Sciences. 2024;25(23):13209. [DOI:10.3390/ijms252313209]

38. Pham HL, Van Pham P. High glucose induces early senescence in adipose-derived stem cells by accelerating p16 and mTOR. Biomedical Research and Therapy. 2019;6(6):3213-21. [DOI:10.15419/bmrat.v6i6.548]

39. Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther. 2023;8(1):92. [DOI:10.1038/s41392-023-01347-1]

40. Ogawara Y, Kishishita S, Obata T, Isazawa Y, Suzuki T, Tanaka K, et al. Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53*. Journal of Biological Chemistry. 2002;277(24):21843-50. [DOI:10.1074/jbc.M109745200]

41. Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nature Reviews Clinical Oncology. 2020;17(7):395-417. [DOI:10.1038/s41571-020-0341-y]

42. Schnerch D, Nigg EA. Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheres. Oncogene. 2016;35(21):2711-22. [DOI:10.1038/onc.2015.332]

43. Goyal A, Afzal M, Khan NH, Goyal K, Srinivasamurthy SK, Gupta G, et al. Targeting p53-p21 signaling to enhance mesenchymal stem cell regenerative potential. Regenerative Therapy. 2025;29:352-63. [DOI:10.1016/j.reth.2025.03.007]